Venetoclax 400

DRUG2 trials

Sponsors

Virginia Commonwealth University, Stichting Hemato-Oncologie voor Volwassenen Nederland

Conditions

Acute Myeloid LeukemiaRefractory Small Cell Lung CarcinomaRelapsed Small Cell Lung Cancer

Phase 1

Venetoclax and Irinotecan in Relapsed/Refractory SCLC

WithdrawnNCT04543916

Virginia Commonwealth UniversityRefractory Small Cell Lung Carcinoma, Relapsed Small Cell Lung Cancer

Start: 2021-06-30End: 2028-06-30Updated: 2021-03-03

Phase 3

Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy

RecruitingNCT07075016

Stichting Hemato-Oncologie voor Volwassenen NederlandAcute Myeloid Leukemia

Start: 2025-08-05End: 2029-03-31Target: 227Updated: 2025-08-19